Active ingredientOsilodrostatCat. No. P-O040-001CAS 928134-65-0Family · Pharmaceutical analytical standards
Osilodrostat
An oral inhibitor of 11-beta-hydroxylase, the enzyme that makes cortisol, approved in 2020 in Europe and the United States for Cushing's disease when surgery is not possible or not curative. This family brings together the active ingredient.
Did you know?It began life as an aldosterone synthase inhibitor for hypertension and primary aldosteronism: when those studies were stopped in 2013, the molecule was repurposed for Cushing's disease.
Go to the active ingredient →Active ingredientOsilodrostatCat. No. P-O040-001CAS 928134-65-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.